David Tanen

David Tanen is a co-founder and Partner of Two River, where he has served as partner since its inception in 2004. David is also a Co-Founder of Kite Pharma, Inc., where he served as Corporate Secretary and General Counsel before its acquisition by Gilead Sciences in 2017. David is also a co-founder of Kronos Bio, Inc., and Neogene Therapeutics, Inc., each a privately held biotechnology company, where he serves as a member of the Board of Directors and Corporate Secretary. He is also a Co-Founder and Corporate Secretary of Allogene Therapeutics, Inc. (ALLO), an advisor to Vida Ventures, LLC, a life science investment firm. David received his B.A. from The George Washington University and his J.D. from Fordham University School of Law, where he has served on the Dean’s Planning Council since 2009.